Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The study reported that once-weekly CagriSema resulted in a significant body weight reduction of 13.7% and a higher percentage of patients achieving an HbA1c level of 6.5% or less, confirming the combination's superior efficacy for both weight loss and glycemic control in this population
However, in June 2025, Novo Nordisk officially launched Wegovy in India as a once-weekly injectable for weight loss
The figures below come from separate trials in different populations, so cross-trial comparisons should be interpreted with caution
Secure the spray cap onto the bottle tightly when transfer is complete
Step 6: Review the Results Check the estimated concentration, mL per dose, syringe measurement, and doses per vial
Data availability All data analyzed in this manuscript are available from the corresponding author on reasonable request
